NKGen Biotech Inc. Common...

NASDAQ: NKGN · Real-Time Price · USD
0.17
0.02 (13.33%)
At close: Apr 29, 2025, 2:52 PM

NKGen Biotech Common Stock Statistics

Share Statistics

NKGen Biotech Common Stock has 50.29M shares outstanding. The number of shares has increased by 75.7% in one year.

Shares Outstanding 50.29M
Shares Change (YoY) 75.7%
Shares Change (QoQ) 27.46%
Owned by Institutions (%) n/a
Shares Floating 22.65M
Failed to Deliver (FTD) Shares 3.75K
FTD / Avg. Volume 0.1%

Short Selling Information

Short Interest n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Valuation Ratios

The PE ratio is -0.51 and the forward PE ratio is null. NKGen Biotech Common Stock's PEG ratio is -0.02.

PE Ratio -0.51
Forward PE n/a
PS Ratio 0
Forward PS n/a
PB Ratio -0.72
P/FCF Ratio -1.93
PEG Ratio -0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for NKGen Biotech Common Stock.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.05, with a Debt / Equity ratio of -0.34.

Current Ratio 0.05
Quick Ratio 0.05
Debt / Equity -0.34
Debt / EBITDA -0.7
Debt / FCF -0.91
Interest Coverage -39.93

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-1.32M
Employee Count 63
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 7K
Effective Tax Rate -0.01%

Stock Price Statistics

The stock price has increased by -90.85% in the last 52 weeks. The beta is 0.83, so NKGen Biotech Common Stock's price volatility has been higher than the market average.

Beta 0.83
52-Week Price Change -90.85%
50-Day Moving Average 0.24
200-Day Moving Average 0.51
Relative Strength Index (RSI) 47.02
Average Volume (20 Days) 3.82M

Income Statement

Revenue n/a
Gross Profit -1.2M
Operating Income -29.75M
Net Income -82.95M
EBITDA -28.54M
EBIT -82.2M
Earnings Per Share (EPS) -5.38
Full Income Statement

Balance Sheet

The company has 26K in cash and 19.92M in debt, giving a net cash position of -19.89M.

Cash & Cash Equivalents 26K
Total Debt 19.92M
Net Cash -19.89M
Retained Earnings -162.13M
Total Assets 14.99M
Working Capital -36.21M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -21.95M and capital expenditures -48K, giving a free cash flow of -22M.

Operating Cash Flow -21.95M
Capital Expenditures -48K
Free Cash Flow -22M
FCF Per Share -1.43
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

NKGN does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for NKGN.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Scores

Altman Z-Score -29.46
Piotroski F-Score 2

Advertisement